Fly News Breaks for October 30, 2017
NVS, AAAP
Oct 30, 2017 | 13:38 EDT
JMP Securities analyst Michael King downgraded Advanced Accelerator (AAAP) to Market Perform from Outperform saying a competing takeover bid to Novartis' (NVS) is unlikely.
News For AAAP;NVS From the Last 2 Days
NVS
Apr 24, 2024 | 07:26 EDT
TD Cowen analyst Yaron Werber raised the firm's price target on BeiGene (BGNE) to $236 from $235 and keeps a Buy rating on the shares. The firm updated its model to reflect lower collaborative revenue given termination of Novartis (NVS) agreement for tisle in Sep 2023.